Pharmaceutical intermediates manufacturer Anlon Healthcare has filed preliminary papers with SEBI for an initial public offering (IPO). The IPO will consist of a fresh issue of 1.4 crore equity shares, with no offer-for-sale component, as per the draft papers filed on October 9.
The Gujarat-based company proposes to use Rs 30.7 crore of the proceeds for expansion of the manufacturing facility, Rs 5 crore for debt repayment, and Rs 35.98 crore towards working capital requirements. It will utilize the balance money to meet acquisition and general corporate purposes.
Anlon Healthcare is a pharmaceutical/API advanced intermediate manufacturer with a portfolio comprising 65 fully commercialized products, besides several under development.
Do you have a news tip for Lakshmishree reporters? Please email us at media@lakshmishree.com
Source: Moneycontrol
News Desk
